Detalles de la búsqueda
1.
Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma.
Cancer Immunol Immunother
; 73(8): 141, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38832974
2.
Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma: A Long-Term Survival Analysis.
Ann Surg Oncol
; 31(6): 3794-3802, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38372864
3.
Development of a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma: Insights into Immune Cell Interactions and Drug Sensitivity.
Cancer Invest
; 42(3): 243-259, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38616306
4.
Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study.
BMC Cancer
; 24(1): 646, 2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38802765
5.
Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis.
BMC Cancer
; 24(1): 654, 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38811891
6.
Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) combined with nimotuzumab for locally advanced esophageal squamous cell carcinoma (ESCC): A phase II clinical trial.
BMC Cancer
; 24(1): 679, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38831450
7.
Endoscopic submucosal dissection for early esophageal squamous cell carcinoma: long-term results from a Western cohort.
Endoscopy
; 56(5): 325-333, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38325394
8.
Impact of deep muscle invasion on nodal status and survival in patients with pT2 esophageal squamous cancer.
J Surg Oncol
; 129(6): 1056-1062, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38314575
9.
Study on the predictive value of pretreatment peripheral blood inflammatory markers regarding immunotherapy in patients with inoperable advanced or locally advanced oesophageal squamous cell carcinoma.
Scand J Gastroenterol
; 59(6): 722-729, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38362884
10.
Clinico-pathological study of esophageal mucoepidermoid carcinoma: a 10-year survival from a single center.
BMC Gastroenterol
; 24(1): 156, 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38720257
11.
Long-term prognosis after endoscopic submucosal dissection for esophageal cancer in older adult patients.
BMC Gastroenterol
; 24(1): 164, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745162
12.
Bioinformatics Analysis Reveals a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma.
Int J Med Sci
; 21(7): 1213-1226, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38818465
13.
Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy.
Dis Esophagus
; 37(5)2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38266034
14.
Exacerbated prognostic impact of multiple intramural metastasis versus single intramural metastasis of thoracic esophageal squamous cell carcinoma: evidence from an Uzbekistan cohort.
Surg Today
; 54(7): 771-778, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38193909
15.
Efficacy and survival of nivolumab treatment for recurrent/unresectable esophageal squamous-cell carcinoma: real-world clinical data from a large multi-institutional cohort.
Esophagus
; 21(3): 319-327, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38717686
16.
The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020.
Gastroenterology
; 163(3): 649-658.e2, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35671803
17.
Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFß-dependent Smad/YAP/TAZ signaling.
PLoS Biol
; 18(9): e3000825, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32886690
18.
Treatment patterns and survival in advanced unresectable esophageal squamous cell cancer: A population-based study.
Cancer Sci
; 113(3): 1038-1046, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34986523
19.
Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma.
Gastroenterology
; 161(6): 1878-1886.e2, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34389340
20.
Soluble PD-L1 Concentration Is Proportional to the Expression of PD-L1 in Tissue and Is Associated with a Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Oncology
; 100(1): 39-47, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34991094